Source comparison
CJC-1295 Growth Hormone Release Research: Pulsatile vs Tonic Secretion
A critical distinction in growth hormone pharmacology is pulsatile versus tonic secretion. Physiological GH release follows an ultradian rhythm. Pulses occur every 3–5 hours, driven by alternating GHRH and somatostatin signalling. Continuous, non-pulsatile GH
This comparison does not assign a generated winner or score.
- A critical distinction in growth hormone pharmacology is pulsatile versus tonic secretion. Physiological GH release follows an ultradian rhythm. Pulses occur every 3–5 hours, driven by alternating GHRH and somatostatin signalling. Continuous, non-pulsatile GH elevation (as seen with exogenous GH administration) causes receptor downregulation, blunted IGF-1 response, and metabolic side effects including insulin resistance.
- CJC-1295 preserves pulsatile secretion architecture. Because it acts as a GHRH analog rather than delivering GH directly, endogenous somatostatin tone still modulates secretion. The peptide amplifies pulse amplitude without eliminating the interpulse nadir. Research published in Drug Metabolism and Disposition confirmed that CJC-1295 administration increased mean 24-hour GH concentrations by 2–10 fold (dose-dependent) while maintaining the characteristic pulsatile pattern observed with native GHRH.
- This pharmacodynamic profile makes CJC-1295 uniquely valuable for studying how physiological GH secretion patterns influence anabolic signalling, metabolic partitioning, and receptor sensitivity. Studies comparing pulsatile GH (GHRH-driven) versus continuous GH infusion show differential effects on lipolysis, protein synthesis, and insulin sensitivity. CJC-1295 allows researchers to study the former without the logistical constraints of repeated GHRH injections.
- Our team has observed that researchers prioritising receptor dynamics and downstream signalling pathways consistently choose CJC-1295 over growth hormone secretagogues like MK-677 (ibutamoren), which produces more tonic elevation. The choice hinges on whether the research question requires mimicking physiological secretion patterns or simply elevating total GH exposure.